Daclatasvir Impurity 12 | CAS 36934-45-9 - Request Quote
Daclatasvir Impurity 12
| SZ CAT No: | SZ-D036049 |
| CAS No | 36934-45-9 |
| Mol.F. | C16H13BrO2 |
| Mol.Wt. | 317.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Daclatasvir Impurity 12 is chemically 1-(4'-acetyl-[1,1'-biphenyl]-4-yl)-2-bromoethan-1-one. Daclatasvir Impurity 12 is supplied with detailed characterization data compliant with regulatory guideline. Daclatasvir Impurity 12 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Daclatasvir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 36934-45-9
Purchase 36934-45-9
Order 36934-45-9
Enquire 36934-45-9
price of 36934-45-9
36934-45-9 Supplier
36934-45-9 Manufacturer
36934-45-9 Exporter
buy high quality Daclatasvir Impurity 12
Purchase Daclatasvir Impurity 12
Daclatasvir Impurity 12 suppliers
Daclatasvir Impurity 12 manufacturers
Daclatasvir Impurity 12 price
Order Daclatasvir Impurity 12
Enquire Daclatasvir Impurity 12
Daclatasvir Impurity 12 cost
Daclatasvir Impurity 12 Supplier
Daclatasvir Impurity 12 Distributor
Daclatasvir Impurity 12 for Method Validation
Daclatasvir Reference Standard
Daclatasvir Impurity 12 for ANDA Filing
Daclatasvir Impurity 12 for Forced Degradation Studies
Daclatasvir Impurity 12 Identification Standards
Daclatasvir Impurity 12 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.